Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dale R Shepard

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Cancer Chemotherapy and Pharmacology|July 6, 2016
Lack of pharmacokinetic drug-drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumorsLaura Q M Chow, David C Smith, Antoinette R Tan, et al.
Cancer Chemotherapy and Pharmacology|August 11, 2016
Lack of pharmacokinetic drug-drug interaction between ramucirumab and irinotecan in patients with advanced solid tumorsDing Wang, Fadi Braiteh, James J Lee, et al.
Journal of Surgical Oncology|June 28, 2018
Adult soft tissue sarcoma and time to treatment initiation: An analysis of the National Cancer DatabaseGannon L Curtis, Joshua M Lawrenz, Jaiben George, et al.
Cancer Chemotherapy and Pharmacology|April 27, 2002
Estimation of the effect of food on the disposition of oral 5-fluorouracil in combination with eniluracilDale R Shepard, Sridhar Mani, Helen Kastrissios, et al.
Pediatric Blood & Cancer|July 17, 2023
Salvage stereotactic body radiation therapy re-irradiation for unresectable locally recurrent nasopharyngeal rhabdomyosarcoma in a young adult: A case reportDavid S Buchberger, Samantha K Cook, Peter M Anderson, et al.
Sarcoma|December 12, 2018
Adult Primary Bone Sarcoma and Time to Treatment Initiation: An Analysis of the National Cancer DatabaseJoshua M Lawrenz, Gannon L Curtis, Joseph F Styron, et al.
Sarcoma|May 27, 2020
Time to Treatment Initiation and Survival in Adult Localized High-Grade Bone SarcomaJoshua M Lawrenz, Joseph Featherall, Gannon L Curtis, et al.
Cancer Chemotherapy and Pharmacology|June 18, 2016
Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumorsDavid C Smith, John Powderly, James J Lee, et al.
Sarcoma|June 1, 2023
Accuracy of Time to Treatment Initiation Data in Musculoskeletal Soft Tissue SarcomaJoshua M Lawrenz, Jose F Vega, Jaiben George, et al.
Journal for Immunotherapy of Cancer|December 6, 2019
A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumorsEzra E W Cohen, Michael J Pishvaian, Dale R Shepard, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Cancer Chemotherapy and Pharmacology|July 6, 2016
Lack of pharmacokinetic drug-drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumorsLaura Q M Chow, David C Smith, Antoinette R Tan, et al.
Cancer Chemotherapy and Pharmacology|August 11, 2016
Lack of pharmacokinetic drug-drug interaction between ramucirumab and irinotecan in patients with advanced solid tumorsDing Wang, Fadi Braiteh, James J Lee, et al.
Journal of Surgical Oncology|June 28, 2018
Adult soft tissue sarcoma and time to treatment initiation: An analysis of the National Cancer DatabaseGannon L Curtis, Joshua M Lawrenz, Jaiben George, et al.
Cancer Chemotherapy and Pharmacology|April 27, 2002
Estimation of the effect of food on the disposition of oral 5-fluorouracil in combination with eniluracilDale R Shepard, Sridhar Mani, Helen Kastrissios, et al.
Pediatric Blood & Cancer|July 17, 2023
Salvage stereotactic body radiation therapy re-irradiation for unresectable locally recurrent nasopharyngeal rhabdomyosarcoma in a young adult: A case reportDavid S Buchberger, Samantha K Cook, Peter M Anderson, et al.
Sarcoma|December 12, 2018
Adult Primary Bone Sarcoma and Time to Treatment Initiation: An Analysis of the National Cancer DatabaseJoshua M Lawrenz, Gannon L Curtis, Joseph F Styron, et al.
Sarcoma|May 27, 2020
Time to Treatment Initiation and Survival in Adult Localized High-Grade Bone SarcomaJoshua M Lawrenz, Joseph Featherall, Gannon L Curtis, et al.
Cancer Chemotherapy and Pharmacology|June 18, 2016
Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumorsDavid C Smith, John Powderly, James J Lee, et al.
Sarcoma|June 1, 2023
Accuracy of Time to Treatment Initiation Data in Musculoskeletal Soft Tissue SarcomaJoshua M Lawrenz, Jose F Vega, Jaiben George, et al.
Journal for Immunotherapy of Cancer|December 6, 2019
A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumorsEzra E W Cohen, Michael J Pishvaian, Dale R Shepard, et al.
Pageof 3